Gaucher Disease in Bone: From Pathophysiology to Practice-Reference-Cited by-同舟云学术

Gaucher Disease in Bone: From Pathophysiology to Practice

Published:2019-06 Issue:6 Volume:34 Page:996-1013
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Hughes Derralynn¹,Mikosch Peter²,Belmatoug Nadia³,Carubbi Francesca⁴,Cox TimothyM⁵,Goker‐Alpan Ozlem⁶,Kindmark Andreas⁷,Mistry PramodK⁸,Poll Ludger⁹,Weinreb Neal¹⁰,Deegan Patrick¹¹

Affiliation:

1. Royal Free London NHS Foundation Trust and University College London UK

2. Department of Internal Medicine 2Landesklinikum Mistelbach, Austria, and Medical University Vienna, Externe Lehre Vienna Austria

3. Referral Center for Lysosomal Diseases, Department of Internal Medicine, University Hospital Paris Nord Val de Seine, Assistance Publique‐Hôpitaux de Paris Clichy France

4. Department of BiomedicalMetabolic and Neural Sciences, University of Modena and Reggio Emilia, NOCSAE Hospital, AOU Modena Italy

5. Department of MedicineUniversity of Cambridge Cambridge UK

6. Lysosomal Disorders Research and Treatment Unit Fairfax VA USA

7. Department of Endocrinology and DiabetologyUppsala University Hospital Uppsala Sweden

8. Department of Internal Medicine (Digestive Diseases)Yale University School of Medicine New Haven CT USA

9. Practice of Radiology and Nuclear Medicine Duisburg‐Moers, Heinrich‐Heine University Düsseldorf Duisburg Germany

10. Departments of Human Genetics and Medicine (Hematology)Miller School of Medicine, University of Miami FL USA

11. Lysosomal Disorders Unit, Addenbrooke's Hospital Cambridge UK

Funder

Sanofi-Genzyme

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbmr.3734

Reference123 articles.

1. The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher’s disease

2. Outcome of type III Gaucher disease on enzyme replacement therapy: Review of 55 cases

3. The risk of Parkinson’s disease in type 1 Gaucher disease

4. Glucocerebrosidase and Parkinson disease: Recent advances

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Soluble mannose receptor: A potential biomarker in Gaucher disease;European Journal of Haematology;2024-01-10

2. Real life data: follow-up assessment on Spanish Gaucher disease patients treated with eliglustat. TRAZELGA project;Orphanet Journal of Rare Diseases;2023-12-15

3. Skeletal Manifestations, Bone Pain, and BMD Changes in Albanian Type 1 Gaucher Patients Treated with Taliglucerase Alfa;Journal of Osteoporosis;2023-12-04

4. The international cooperative Gaucher group (ICCG) Gaucher registry;Best Practice & Research Clinical Haematology;2023-12

5. SAME BUT DIFFERENT: GAUCHER DISEASE Rare Cases of Gaucher in Two Siblings with the Same Genotype but Different Phenotype;2023-11-28